Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Two Lots of Noven, Shire ADHD Patch Recalled
Link ID 8112
Title Two Lots of Noven, Shire ADHD Patch Recalled
Url http://www.medscape.com/viewarticle/579569?src=rss
Description Noven Pharmaceuticals Inc said on Monday that its marketing partner, Shire Ltd, is voluntarily recalling two batches of its skin patch to treat attention-deficit/hyperactivity disorder, because of difficulties removing the release liner when the patch is peeled open. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Aug 27, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Bivalirudin "Nonapprovable" for ACUITY Indication
  The US FDA has issued a "not-approvable" letter to the Medicines Company for an additional dosing regimen of the drug covering upstream treatment of ACS initiated in the emergency department, based on the ACUITY trial. Heartwire
Category:   Articles > Business of Medicine


2. Experts Assess How the Internet is Changing Doctor-Patient Interactions
  Patients are increasingly going online for health information — a trend that is shifting the clinical landscape. Panelists discuss how oncologists might address this phenomenon. Medscape Medical News
Category:   Articles > Business of Medicine


3. FDA Backpedals on Warnings in Echo-Contrast Labeling
  Warnings and contraindications imposed late last year have been softened after the agency heard from the medical community. Heartwire
Category:   Articles > Business of Medicine


4. Developing Quality Measures for Care Transitions
  NMA 2007: Passing the patient on should not be passing the buck: a toolkit for transitions.
Medscape Internal Medicine
Category:   Articles > Business of Medicine


5. FDA Approvals: Prilosec and Treanda
  The FDA has approved an expanded indication for omeprazole delayed-release capsules and oral suspension (Prilosec), and bendamustine intravenous infusion (Treanda). Medscape Medical News
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS